# US 2020/0188426 A1 · Wound management method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0188426 A1
- Document ID: US20200188426A1
- Status: Published application
- Kind: A1
- Application number: 16/713,922
- Filed: 2019-12-13
- Published: 2020-06-18
- Earliest claimed: 2018-12-14
- Assignees: Prevent-Plus, LLC
- Applicants: Prevent-Plus, LLC
- Inventors: Julie Marie Morris; Jeffrey Steven Elbl
- Web page: https://patentgrep.com/patent/US20200188426A1

## CPC

- A61K 31/765: Polymers containing oxygen
- A61K 9/7007: {Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence)}
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 33/20: Elemental chlorine; Inorganic compounds releasing chlorine
- A61L 26/0019: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds}
- A61M 35/30: {Gas therapy for therapeutic treatment of the skin}
- A61B 5/445: {Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore}
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61M 2202/0225: Carbon oxides, e.g. Carbon dioxide
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method for wound management in the prevention of bioburden and/or biofilm includes conducting an initial risk assessment protocol with regard to a wound, washing the wound and surrounding skin, applying a polyethylene carbonate composition on and around the wound, eradicating any organisms as methylene chloride of the polyethylene carbonate composition evaporates and polyethylene carbonate polymer of the polyethylene carbonate composition polymerizes, and allowing time for formation of a clear elastomeric film barrier over the wound and around the wound.

## Claims

### Claim 1

A method for wound management in prevention of bioburden and/or biofilm, comprising:
conducting an initial risk assessment protocol with regard to a wound;
washing the wound and surrounding skin;
applying a polyethylene carbonate composition on and around the wound;
eradicating any organisms as methylene chloride of the polyethylene carbonate composition evaporates and polyethylene carbonate polymer of the polyethylene carbonate composition polymerizes;
allowing time for formation of a clear elastomeric film barrier over the wound and around the wound.

### Claim 2 (depends on 1)

The method according to claim 1, further including the step of releasing CO2 into the wound as the polyethylene carbonate polymer of the polyethylene carbonate composition polymerizes and forms the elastomeric film barrier.

### Claim 3 (depends on 1)

The method according to claim 1, further including the step of providing a barrier to the flow of O2 into and from the wound after the elastomeric film barrier is formed.

### Claim 4 (depends on 1)

The method according to claim 1, further including the step of visually inspecting the wound, on a daily basis, through the elastomeric film barrier to identify potential indicators of bioburden, biofilm, and/or maceration.

### Claim 5 (depends on 1)

The method according to claim 1, further including the step of inspecting the elastomeric film barrier for leakage and loosening of edges.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the step of conducting an initial risk assessment includes visually inspecting to identify existing bioburden and prior development of biofilm, determining non-healing status of the wound, identifying personal characteristics leading to susceptibility to the development of bioburden and/or biofilm, and identifying potential medical procedures conflicting with conventional wound treatment protocols.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the step of washing further includes cleaning and drying the wound and surrounding skin.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the step of applying includes covering an area that extends at least one and one-quarter inches beyond edges of the wound with the polyethylene carbonate composition.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the polyethylene carbonate composition includes polyethylene carbonate polymer dissolved in methylene chloride.
